WELL, GOOD: “In the paper, ‘Ranitidine Use and Incident Cancer in a Multinational Cohort,’ published in JAMA Network Open, the researchers claim that despite contamination with a probable human carcinogen N-nitrosodimethylamine (NDMA) found in ranitidine, there was no statistically significant evidence that exposure to the drug was associated with an increased risk of cancer.”